EIP Pharma
Boston
About EIP Pharma
EIP Pharma is a clinical stage therapeutics company that focuses on the development and commercialization of drug treatments for neurodegenerative diseases, with a particular emphasis on the early stages of the neurodegenerative process. The company's drug promotes function recovery in patients suffering from acute neurologic injury.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $59.6M
- Funding stage: M&A
- Last round: Grant (Jan 2023)
- Website: eippharma.com
- Phone: (617) 863-3751
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical, Service Industry
Social Profiles
Canonical: https://fsome.com/organization/eip-pharma-37263 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.